Prevalence and risk factors for in-hospital mortality of adult patients on veno-arterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: A …

YJ Son, SH Park, Y Lee, HJ Lee - Intensive and Critical Care Nursing, 2024 - Elsevier
Objectives To synthesize quantitative research findings on the prevalence and risk factors
for in-hospital mortality of patients on veno-arterial extracorporeal membrane oxygenation …

Short‐Term Mortality Among Pediatric Patients With Heart Diseases Undergoing Veno‐Arterial Extracorporeal Membrane Oxygenation: A Systematic Review and …

J Zhou, H Wang, Y Zhao, J Shao, M Jiang… - Journal of the …, 2023 - Am Heart Assoc
Background Veno‐arterial extracorporeal membrane oxygenation serves as a crucial
mechanical circulatory support for pediatric patients with severe heart diseases, but the …

Impella device in fulminant myocarditis: Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD) registry analysis on outcomes and adverse events

T Nasu, R Ninomiya, Y Koeda… - European Heart Journal …, 2024 - academic.oup.com
Aims Given that fulminant myocarditis, characterized by unstable haemodynamics, is a
significant clinical challenge and that traditional pharmacological treatments have …

2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of …

Writing Committee, MH Drazner, B Bozkurt… - Journal of the American …, 2025 - jacc.org
10. Further research on a wide range of factors is needed. These include how social
determinants of health impact the development and progression of myocarditis; a need for …

Tailored Therapy in Cardiogenic Shock: Case-Based Management Choices

SS Patlolla, AH Alam, JN Katz, SA Hall - The American Journal of …, 2024 - Elsevier
Cardiogenic shock (CS) is a complex, multisystem disorder precipitated by hypoperfusion
from cardiac dysfunction. Our current approach to defining and treating CS encompasses all …

Viral cardiovascular surgical diseases: global burdens, challenges and opportunities

Z Gomes, GS Lee, S Mesfin, R Rocha… - Future …, 2024 - Taylor & Francis
Globally, more than one billion people are vulnerable to neglected tropical diseases, many
of which have viral origins and cardiovascular implications. Access to cardiovascular care is …

Comparison of predictors of survival among fulminant myocarditis patients undergoing veno-arterial extracorporeal membrane oxygenation in the adult and pediatric …

YE Dean, M Doma, A Afzal, SS Elawady… - Annals of Medicine …, 2024 - journals.lww.com
Background: Fulminant myocarditis (FM) is a potentially life-threatening disease that
requires emergency care. The authors' study aims to explore clinical outcomes and …

[HTML][HTML] Is Extracorporeal Membrane Oxygenation a Panacea?

S Karaoğlanoğlu, M Akgün - The Eurasian Journal of Medicine, 2023 - ncbi.nlm.nih.gov
Extracorporeal membrane oxygenation (ECMO) has emerged as a vital life-support
technique in critical care medicine, providing temporary circulatory and/or respiratory …

Successful rescue of fulminant myocarditis with mechanical circulatory support and immunosuppression therapy: A case report

C Zhou - Frontiers in Cardiovascular Medicine, 2023 - frontiersin.org
Myocarditis is challenging to diagnose because of its various clinical manifestations.
Fulminant myocarditis (FM) is a severe type of myocarditis characterized by heart failure …

[HTML][HTML] Clinical Application of Extracorporeal Membrane Oxygenation in the Treatment of Fulminant Myocarditis

Z Fan, J Wen, B Li, X Liao - Reviews in Cardiovascular Medicine, 2024 - imrpress.com
Fulminant myocarditis (FM) is a rare but serious clinical syndrome which can be
characterized by the rapid deterioration of cardiac function, with cardiogenic shock (CS) and …